Vision and Goals

Saniona aims to be a leading biotech company focusing on treatment of diseases of the central nervous system and eating disorders. Saniona’s overall objective is to develop - both in-house and together with partners - new treatments that address significant unmet medical needs. Strategically, the company intends to develop and commercialize treatments for orphan indications on its own and engage in partnerships with larger pharmaceutical companies for development programs aiming at treating large indications such as obesity.